Effects of cardioselective β-blockers on dynamic hyperinflation in moderate-to-severe COPD

V. Mainguy, D. Girard, D. Saey, J. Milot, F. Maltais, S. Provencher (Quebec, Canada)

Source: Annual Congress 2010 - Bronchodilators in airways disease
Session: Bronchodilators in airways disease
Session type: Oral Presentation
Number: 5561
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Mainguy, D. Girard, D. Saey, J. Milot, F. Maltais, S. Provencher (Quebec, Canada). Effects of cardioselective β-blockers on dynamic hyperinflation in moderate-to-severe COPD. Eur Respir J 2010; 36: Suppl. 54, 5561

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of indacaterol maleate on dynamic lung hyperinflation in patients with COPD
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 172s
Year: 2006

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD
Source: Eur Respir J, 53 (3) 1802049; 10.1183/13993003.02049-2018
Year: 2019



Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006

Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006

Effects of tiotropium on neurohumoral activation during exercise in stable COPD patients
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Effects of pulmonary rehabilitation on dynamic hyperinflation during exercise in severe COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 719s
Year: 2005

Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016

Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015


Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013

Rapid onset bronchodilation with formoterol or salbutamol in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 514s
Year: 2001

Effects of acute dual bronchodilator treatment (tiotropium + olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD
Source: International Congress 2018 – Advances in exercise physiopathology
Year: 2018



Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Pre-exercise inhalation of short-acting ß-agonists (SABA) safely improves exercise performance in severe COPD patients by reducing lung hyperinflation
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 639-644
Year: 2002



Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014

Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 294s
Year: 2005

Dynamic hyperinflation during exercise in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 357s
Year: 2001

Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
Source: Eur Respir J 2004; 23: 825-831
Year: 2004